Provided by Tiger Fintech (Singapore) Pte. Ltd.

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD

2.06
-0.0600-2.83%
Volume:46.33K
Turnover:95.57K
Market Cap:1.38M
PE:-0.05
High:2.11
Open:2.05
Low:2.00
Close:2.12
Loading ...

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading

MT Newswires Live
·
10 Mar

Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP

GlobeNewswire
·
10 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live
·
08 Mar

Biodexa Pharmaceuticals announces appointment of Precision for Medicine as CRO

TIPRANKS
·
06 Mar

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP

GlobeNewswire
·
06 Mar

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading

MT Newswires Live
·
04 Mar

Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading

MT Newswires Live
·
26 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
25 Feb

Biodexa Pharmaceuticals announces allowance of U.S. patent covering eRapa

TIPRANKS
·
24 Feb

Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use

GlobeNewswire
·
24 Feb

European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading

MT Newswires Live
·
14 Feb

Biodexa Pharmaceuticals PLC to Present at the Emerging Growth Conference on February 19, 2025

GlobeNewswire
·
13 Feb

Biodexa Pharmaceuticals receives Fast Track designation for eRapa

TIPRANKS
·
12 Feb

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status

ACCESS Newswire
·
12 Feb

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
12 Feb

Top Midday Gainers

MT Newswires Live
·
11 Feb